COMP <GO>
OHI vs BAC // EV/EBITDA & P/E VALUATION
Omega Healthcare Investors Inc. (NYSE) VS. Bank of America Corporation (NYSE) • 15-METRIC TALLY: OHI 7
— BAC 7
▲ EV/EBITDA & P/E VALUATION LEADER: BAC
LAST: $46.98 (+0.30%) • MKT CAP: $14.19B
valuation
95.0x
LAST: $50.01 (-2.21%) • MKT CAP: $357.61B
valuation
30.2x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (OHI VS. BAC)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | OHI | BAC | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | 41.00% | 0.00 | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 0.00% | 2.50% | -2.50 | BAC | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 95.0x | 30.2x | +64.80 | BAC | /valuation <GO> |
| Free Cash Flow Yield | 5.81% | 2.10% | +3.71 | OHI | /fcf-yield <GO> |
| Operating Margin | 0.10% | 32.90% | -32.80 | BAC | /operating-margins <GO> |
| Net Profit Margin | 0.10% | 27.00% | -26.90 | BAC | /net-margins <GO> |
| Revenue Growth (YoY) | 13.20% | 6.80% | +6.40 | OHI | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 5.50% | 0.00% | +5.50 | OHI | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.89 | 0.45 | +2.44 | OHI | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 7/9 | +2.00 | OHI | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.20% | 6.60% | +0.60 | BAC | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 56.8 | 27.7 | +29.13 | OHI | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.08 | 0.90 | +0.18 | OHI | /macro-sensitivity <GO> |
| Forward P/E Multiple | 140.0x | 10.9x | +129.10 | BAC | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $14.19B | $357.61B | -$343.42B | BAC | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | OHI REV | BAC REV | OHI GROSS % | BAC GROSS % | OHI FCF | BAC FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.19B | $113.10B | 44.0% | 44.0% | $825.0M | $7.52B |
| FY 2024 | $1.05B | $105.86B | 44.0% | 44.0% | $702.1M | -$13.57B |
| FY 2023 | $949.7M | $102.77B | 44.0% | 44.0% | $575.0M | $40.36B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
OHI // BETA 1.08
BAC // BETA 0.90